Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hypertension: HELP
Articles by Dr. George Bakris
Based on 221 articles published since 2009
(Why 221 articles?)
||||

Between 2009 and 2019, G. Bakris wrote the following 221 articles about Hypertension.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9
1 Guideline Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. 2018

Carey, Robert M / Calhoun, David A / Bakris, George L / Brook, Robert D / Daugherty, Stacie L / Dennison-Himmelfarb, Cheryl R / Egan, Brent M / Flack, John M / Gidding, Samuel S / Judd, Eric / Lackland, Daniel T / Laffer, Cheryl L / Newton-Cheh, Christopher / Smith, Steven M / Taler, Sandra J / Textor, Stephen C / Turan, Tanya N / White, William B / Anonymous191225. · ·Hypertension · Pubmed #30354828.

ABSTRACT: Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a long-acting calcium channel blocker, a blocker of the renin-angiotensin system (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker), and a diuretic. The antihypertensive drugs should be administered at maximum or maximally tolerated daily doses. RH also includes patients whose BP achieves target values on ≥4 antihypertensive medications. The diagnosis of RH requires assurance of antihypertensive medication adherence and exclusion of the "white-coat effect" (office BP above goal but out-of-office BP at or below target). The importance of RH is underscored by the associated risk of adverse outcomes compared with non-RH. This article is an updated American Heart Association scientific statement on the detection, evaluation, and management of RH. Once antihypertensive medication adherence is confirmed and out-of-office BP recordings exclude a white-coat effect, evaluation includes identification of contributing lifestyle issues, detection of drugs interfering with antihypertensive medication effectiveness, screening for secondary hypertension, and assessment of target organ damage. Management of RH includes maximization of lifestyle interventions, use of long-acting thiazide-like diuretics (chlorthalidone or indapamide), addition of a mineralocorticoid receptor antagonist (spironolactone or eplerenone), and, if BP remains elevated, stepwise addition of antihypertensive drugs with complementary mechanisms of action to lower BP. If BP remains uncontrolled, referral to a hypertension specialist is advised.

2 Guideline Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. 2014

Weber, Michael A / Schiffrin, Ernesto L / White, William B / Mann, Samuel / Lindholm, Lars H / Kenerson, John G / Flack, John M / Carter, Barry L / Materson, Barry J / Ram, C Venkata S / Cohen, Debbie L / Cadet, Jean-Claude / Jean-Charles, Roger R / Taler, Sandra / Kountz, David / Townsend, Raymond R / Chalmers, John / Ramirez, Agustin J / Bakris, George L / Wang, Jiguang / Schutte, Aletta E / Bisognano, John D / Touyz, Rhian M / Sica, Dominic / Harrap, Stephen B. ·State University of New York, Downstate College of Medicine, Brooklyn, NY. ·J Clin Hypertens (Greenwich) · Pubmed #24341872.

ABSTRACT: -- No abstract --

3 Guideline Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. 2014

Weber, Michael A / Schiffrin, Ernesto L / White, William B / Mann, Samuel / Lindholm, Lars H / Kenerson, John G / Flack, John M / Carter, Barry L / Materson, Barry J / Ram, C Venkata S / Cohen, Debbie L / Cadet, Jean-Claude / Jean-Charles, Roger R / Taler, Sandra / Kountz, David / Townsend, Raymond / Chalmers, John / Ramirez, Agustin J / Bakris, George L / Wang, Jiguang / Schutte, Aletta E / Bisognano, John D / Touyz, Rhian M / Sica, Dominic / Harrap, Stephen B. ·aState University of New York, Downstate College of Medicine, Brooklyn, New York, USA bDepartment of Medicine, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada cCalhoun Cardiology Center, University of Connecticut, Farmington, Connecticut dDepartment of Medicine, Weil Cornell College of Medicine, New York, New York, USA eDepartment of Public Health and Clinical Medicine, Umea University, Umea, Sweden fCardiovascular Associates, Virginia Beach, Virginia gDepartment of Medicine, Wayne State University, Detroit, Michigan hDepartment of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa iDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA jMediCiti Institutions, Hyderabad, India kDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA lState University School of Medicine mHypertension Center of Haiti, Port-au-Prince, Haiti nDepartment of Medicine, Mayo Clinic, Rochester, Minnesota oJersey Shore University Medical Center, Neptune, New Jersey pHypertension Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA qGeorge Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia rArterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina sASH Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois, USA tThe Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China uHypertension in Africa Research Team, North West University, Potchefstroom, South Africa vDepartment of Medicine, University of Rochester Medical Center, Rochester, New York, USA wInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Lanarkshire, UK xVirginia Commonwealth University, Richmond, Virginia, USA yDepartment of Physiology, University of Melbourne, Melbourne, Australia. ·J Hypertens · Pubmed #24270181.

ABSTRACT: -- No abstract --

4 Guideline Combination therapy in hypertension. 2010

Gradman, Alan H / Basile, Jan N / Carter, Barry L / Bakris, George L / Anonymous4880657. ·The Western Pennsylvania Hospital, Pittsburgh, Pennsylvania and Temple University School of Medicine, Philadelphia, PA 15224, USA. grandmamd@aol.com ·J Am Soc Hypertens · Pubmed #20374950.

ABSTRACT: The goal of antihypertensive therapy is to abolish the risks associated with blood pressure (BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy in lowering BP and in reducing cardiovascular (CV) end points including stroke, myocardial infarction, and heart failure. Although the choice of initial drug therapy exerts some effect on long-term outcomes, it is evident that BP reduction per se is the primary determinant of CV risk reduction. Available data suggest that at least 75% of patients will require combination therapy to achieve contemporary BP targets, and increasing emphasis is being placed on the practical tasks involved in consistently achieving and maintaining goal BP in clinical practice. It is within this context that the American Society of Hypertension presents this Position Paper on Combination Therapy for Hypertension. It will address the scientific basis of combination therapy, present the pharmacologic rationale for choosing specific drug combinations, and review patient selection criteria for initial and secondary use. The advantages and disadvantages of single pill (fixed) drug combinations, and the implications of recent clinical trials involving specific combination strategies will also be discussed.

5 Editorial Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension? 2018

Laffin, Luke J / Bakris, George L. ·From the Section of Cardiology (L.J.L.), Department of Medicine, University of Chicago Medicine, IL. · The Comprehensive Hypertension Center, Section of Endocrinology, Diabetes and Metabolism (L.J.L., G.L.B.), Department of Medicine, University of Chicago Medicine, IL. ·Hypertension · Pubmed #30354732.

ABSTRACT: -- No abstract --

6 Editorial Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes. 2018

Laffin, Luke J / Bakris, George L. ·Section of Cardiology, Department of Medicine, University of Chicago Medicine, Chicago, Illinois. · ASH Comprehensive Hypertension Center, Section of Endocrinology, Department of Medicine, University of Chicago Medicine, Chicago, Illinois. ·Diabetes Obes Metab · Pubmed #29424470.

ABSTRACT: -- No abstract --

7 Editorial Consequences of Overinterpreting Serum Creatinine Increases when Achieving BP Reduction: Balancing Risks and Benefits of BP Reduction in Hypertension. 2018

Yamout, Hala / Bakris, George L. ·Department of Medicine, Division of Nephrology, St. Louis University Medical Center, St. Louis, Missouri. · John Cochran Division, Veterans Affairs St. Louis Health Care System, St. Louis, Missouri; and. · American Society of Hypertension Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois gbakris@medicine.bsd.uchicago.edu. ·Clin J Am Soc Nephrol · Pubmed #29101187.

ABSTRACT: -- No abstract --

8 Editorial Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People? 2017

Al Dhabyi, Omar / Bakris, George L. ·Department of Medicine, ASH Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL. · Department of Medicine, ASH Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL gbakris@medicine.bsd.uchicago.edu. ·J Am Heart Assoc · Pubmed #29151038.

ABSTRACT: -- No abstract --

9 Editorial Resistant Hypertension: A Refractory Disease or Refractory Patient. 2017

Sternlicht, Hillel / Bakris, George L. ·1 Section of Nephrology and Hypertension, Department of Medicine, Lenox Hill Hospital, New York, NY; · 2 ASH Comprehensive Hypertension Center, Department of Medicine, The University of Chicago, Chicago, IL. gbakris@medicine.bsd.uchicago.edu. ·Hypertension · Pubmed #28264919.

ABSTRACT: -- No abstract --

10 Editorial Searching for the Optimal Blood Pressure Range in the Elderly: Are We There Yet? 2017

Bakris, George / Briasoulis, Alexandros. ·ASH Comprehensive Hypertension Center, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois. Electronic address: gbakris@gmail.com. · Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. ·J Am Coll Cardiol · Pubmed #28153105.

ABSTRACT: -- No abstract --

11 Editorial Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit. 2016

Sternlicht, Hillel / Bakris, George L. ·Department of Medicine, ASH Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois. · Department of Medicine, ASH Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois. Electronic address: gbakris@gmail.com. ·J Am Coll Cardiol · Pubmed #26821626.

ABSTRACT: -- No abstract --

12 Editorial In search for the 'sweet spot' for blood pressure level in diabetes. 2014

Yamout, Hala / Bakris, George L. ·Department of Medicine, The ASH Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, Illinois, USA. ·Heart · Pubmed #25073888.

ABSTRACT: -- No abstract --

13 Editorial Early patterns of blood pressure change and future coronary atherosclerosis. 2014

Sarafidis, Pantelis A / Bakris, George L. ·Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Department of Medicine, ASH Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois. ·JAMA · Pubmed #24496535.

ABSTRACT: -- No abstract --

14 Editorial Initial single-pill combination therapy for cardiovascular risk factor management: it is not just convenience. 2013

Briasoulis, Alexandros / Bakris, George. · ·J Hypertens · Pubmed #23822927.

ABSTRACT: -- No abstract --

15 Editorial Lowering blood pressure limits in patients with type 2 diabetes: is it still warranted? 2013

Bakris, George L. ·ASH Comprehensive Hypertension Center, Section of Endocrinology, Diabetes, and Metabolism, The University of Chicago Medicine, Chicago, IL USA. Electronic address: gbakris@gmail.com. ·J Diabetes Complications · Pubmed #23659775.

ABSTRACT: -- No abstract --

16 Editorial The promise of renal denervation. 2012

Bhatt, Deepak L / Bakris, George L. ·VA Boston Healthcare System, Integrated Interventional Cardiovascular Program, Brigham and Women's Hospital & VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA. dlbhattmd@post.harvard.edu ·Cleve Clin J Med · Pubmed #22751634.

ABSTRACT: -- No abstract --

17 Editorial Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. 2012

Doumas, Michael / Anyfanti, Panagiota / Bakris, George. · ·J Hypertens · Pubmed #22495128.

ABSTRACT: Recent technologic advances rekindled interventional management of resistant hypertension, either by carotid baroreceptor activation or renal sympathetic denervation. Interventional techniques result in impressive falls in office blood pressure (BP); however, ambulatory BP reductions are rather modest. This disparity between office and ambulatory BP reductions is observed with antihypertensive drugs, but at a much lower degree. Available explanations are not convincing, therefore, we propose that sympathetic overactivity may partially explain this divergence. Further studies are needed to prove or disprove our hypothesis.

18 Editorial The United Nations high level meeting addresses noncommunicable diseases, but where is hypertension? 2011

Mensah, George A / Bakris, George. · ·J Clin Hypertens (Greenwich) · Pubmed #22051421.

ABSTRACT: -- No abstract --

19 Editorial More complete renin-angiotensin system blockade: better outcomes or smoke and mirrors. 2010

Bakris, George L / Bidani, Anil. · ·J Hypertens · Pubmed #20574248.

ABSTRACT: -- No abstract --

20 Editorial The future of blood pressure control in a population with a growing girth. 2009

Bakris, George L. · ·Curr Opin Nephrol Hypertens · Pubmed #19623066.

ABSTRACT: -- No abstract --

21 Editorial The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented. 2009

Bakris, George L / Ritz, Eberhard. · ·Nephrology (Carlton) · Pubmed #19335844.

ABSTRACT: -- No abstract --

22 Editorial The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented. 2009

Bakris, G L / Ritz, E / Anonymous410624. · ·Clin Nephrol · Pubmed #19281733.

ABSTRACT: -- No abstract --

23 Editorial The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. 2009

Bakris, George L / Ritz, Eberhard. · ·Kidney Int · Pubmed #19218998.

ABSTRACT: -- No abstract --

24 Editorial The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. 2009

Bakris, George L / Ritz, Eberhard / Anonymous5220621. · ·Clin J Am Soc Nephrol · Pubmed #19211670.

ABSTRACT: -- No abstract --

25 Editorial The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented. 2009

Bakris, G L / Ritz, E / Anonymous1080620. · ·J Hum Hypertens · Pubmed #19158823.

ABSTRACT: The prevalence of chronic kidney disease (CKD) continues to increase worldwide as does end stage renal disease. The most common, but not the only, causes of CKD are hypertension and diabetes. CKD is associated with a significant increase in cardiovascular (CV) risk as most patients with CKD die of a CV cause. Moreover, CV risk increases proportionally as eGFR falls below 60 ml min(-1). CV causes of death in CKD are more prevalent than those from cancer are; as a result, the identification and reduction of CKD is a public health priority. High blood pressure is a key pathogenic factor that contributes to the deterioration of kidney function. The presence of kidney disease is a common and underappreciated pre-existing medical cause of resistant hypertension. Therefore, treatment of hypertension has become the most important intervention in the management of all forms of CKD. For this reason, the forthcoming World Kidney Day on 12 March 2009 will emphasize the role of hypertension.

Next